Viemed Healthcare, Inc.
High uncertainty:The valuation methods show significant disagreement (>100% spread). Treat the range as a rough guide rather than a precise estimate.
Bear Case (25th pct.)
-53.3% vs price
Base Case (Median)
-26.3% vs price
Bull Case (75th pct.)
31.0% vs price
◇ = Current price | |Bear |Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $0.39 | -95.7% | High (40%) |
| PE Comparable | $8.01 | -12.2% | Medium (25%) |
| Graham Number | $5.43 | -40.5% | Medium (40%) |
| EV/EBITDA | $13.26 | 45.4% | Medium (20%) |
| EV/FCF | $15.03 | 64.8% | Medium (20%) |
| Earnings Power Value | $3.86 | -57.6% | Medium (50%) |
Based on 6 out of 8 methods, VMD appears fairly valued at the current price of $9.12. The base case fair value of $6.72 implies 26.3% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.